Searchable abstracts of presentations at key conferences in endocrinology

ea0044p43 | Bone and Calcium | SFEBES2016

The influence of gender on the bone health of adolescent patients with hormonal deficiencies

Whittingham Pauline , Grounds Kerrie , Ahmad Aftab , Didi Mo , Corlett Pamela

Introduction: Previous audits demonstrated low bone mineral density (BMD) in adolescent patients with hormone deficiencies. We wanted to ascertain if gender had any relationship with the development of low BMD.Method: A retrospective analysis of 42 Transitional clinic patients who underwent DEXA scanning was made using case notes and hospital systems. Follow-up data was gathered as previous audit of 25 transitional patients had shown a significant number...

ea0044p76 | Clinical biochemistry | SFEBES2016

Time taken for GH-treated adolescent patients, transitioning to adult services, to reach IGF1 levels within the upper normal range: Do we need to monitor more frequently?

Grounds Kerrie , Whittingham Pauline , Didi Mo , Ahmad Aftab

Introduction: According to NICE: adults receiving growth hormone (GH) treatment, IGF1 levels should reach therapeutic range by 9 months. Patients are reviewed at 1, 3, 6, 9, 12 months and 6 months thereafter in our clinics. GH dose is titrated by 0.1 mg each visit. This work aims to compare the time it takes to get the IGF1 in range, between adults and adolescent patients attending our specialist regional clinics.Method: We performed a retrospective audi...

ea0036P62 | (1) | BSPED2014

Lanreotide therapy for congenital hyperinsulinism

Giri Dinesh , Yung Zoe , Didi Mo , Senniappan Senthil

Introduction: Congenital hyperinsulinism (CHI) is the commonest cause of recurrent and persistent hypoglycaemia during the newborn period. The management of CHI in patients who are unresponsive or do not tolerate diazoxide includes the use of octreotide therapy which is given as a SUBCUTANEOUS injection, three to four times daily. We report a case of persistent CHI successfully treated with once monthly Lanreotide (a long acting somatostatin analogue).<p cla...

ea0036P63 | (1) | BSPED2014

Hyperinsulinaemic hypoglycaemia and cochlear hypoplasia in a rare case of Pallister–Hall syndrome

Giri Dinesh , Mulvey Ian , Avula Shivaram , Weber Astrid , Didi Mo , Senniappan Senthil

Introduction: Pallister–Hall syndrome (PHS) is characterized by a spectrum of anomalies which includes polydactyly, hypothalamic hamartoma, laryngotracheal cleft, bifid epiglottis, imperforate anus, and renal abnormalities. Hypoplastic cochlea is an infrequently reported association of PHS. The association of PHS with hyperinsulinaemic hypoglycaemia (HH) has not been previously reported in the literature.Case report: A baby girl was born by elective...

ea0023oc4.3 | Oral Communications 4 | BSPED2009

Pituitary adenomas presenting in children and young people: a single centre experience

Steele Caroline , Blair Jo , Didi Mo , Javadpour Mohsen , MacFarlane Ian , Daousi Christina

Introduction: Pituitary adenomas are uncommon in childhood and adolescence and knowledge of long-term outcomes is sparse. We describe a large cohort of patients, now attending our adult clinic.Patients and methods: Retrospective review of patients aged ≤18 years at diagnosis of a pituitary adenoma.Results: There were 24 patients (18 female), mean age at diagnosis 15.6 (range 11–18) years, current age 25.5 (14–47). O...

ea0036P20 | (1) | BSPED2014

Denosumab therapy for refractory hypercalcaemia secondary to squamous cell carcinoma of skin

Giri Dinesh , Das Urmi , Blair Jo , Didi Mo , Hayden James , Brook Lynda , Selby Peter , Senniappan Senthil , Dharmaraj Poonam

Introduction: Hypercalcaemia secondary to malignancy is rare in children. PTH-rP secreted by malignant cells increases bone resorption and renal calcium retention causing hypercalcaemia. We report a case of hypercalcaemia refractory to bisphosphonate and corticosteroid therapy, but responsive to treatment with Denosumab.Case report: A 17-year-old boy with epidermolysis bullosa presented with advanced squamous cell carcinoma of the left leg and symptomati...